MedPath
NMPA Approval

Parecoxib Sodium for Injection

国药准字H20193247

May 11, 2024

Drug Information

注射用帕瑞昔布钠

注射剂

40mg(按C₁₉H₁₈N₂O₄S计)

化学药品

May 11, 2024

Company Information

Applicant Company

峨眉山市加工仓储物流园通惠路

Manufacturing Company

峨眉山市加工仓储物流园通惠路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用帕瑞昔布钠 - NMPA 批准文号 | MedPath